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Autophagy is an important intracellular homeostatic mechanism for the targeting of cytoso-
lic constituents, including organelles, for lysosomal degradation. Autophagy plays roles in
numerous physiological processes, including immune cell responses to endogenous and
exogenous pathogenic stimuli. Moreover, autophagy has a potentially pivotal role to play in
the regulation of inflammatory responses. In particular, autophagy regulates endogenous
inflammasome activators, as well as inflammasome components and pro-IL-1β. As a result,
autophagy acts a key modulator of IL-1β and IL-18, as well as IL-1α, release. This review
focuses specifically on the role autophagy plays in regulating the production, processing,
and secretion of IL-1 and IL-18 and the consequences of this important function.
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INTRODUCTION
Autophagy exists in three forms. Microautophagy describes the
direct engulfment of small volumes of cytosol by lysosomes
(Ahlberg et al., 1982). Alternatively, in chaperone-mediated
autophagy specific proteins are recognized by a cytosolic chap-
erone and targeted to the lysosome (Dice, 1990). This review will
focus on macroautophagy (hereafter referred to as autophagy),
a highly conserved homeostatic mechanism for the lysosomal
degradation and recycling of cytosolic components, including
macromolecules and organelles (Shintani and Klionsky, 2004).
Macroautophagy is characterized by the formation of an isola-
tion membrane, or phagophore, which elongates around its target
and fuses with itself to form a double-membraned autophago-
some. This can then fuse with lysosomes to form an autolysosome,
leading to degradation of the luminal contents.
Autophagy acts as an important survival mechanism, seques-
tering and degrading damaged/toxic cytosolic constituents, such
as dysfunctional mitochondria or peroxisomes. In addition,
autophagy regulates energy and nutrient homeostasis and plays
an essential role in development (Yang and Klionsky, 2010).
Autophagy can be induced by numerous different stimuli, includ-
ing environmental and cellular stresses, such as nutrient depriva-
tion/amino acid starvation, growth factor withdrawal, and endo-
plasmic reticulum (ER) stress (Lum et al., 2005; Ogata et al., 2006;
Yorimitsu et al., 2006).
Autophagy can also regulate a number of important immune
responses, including clearance of intracellular bacteria (Deretic,
2010), antigen presentation (Munz, 2010), and the regulation
of cytokine production and secretion (Harris, 2011). In addi-
tion, autophagy is important for immune cell homeostasis;
deficiencies in the autophagy pathway cause defects in ER and
leave T cells more prone to cell death (Jia and He, 2011; Jia et al.,
2011) and is required for immunoglobulin production by plasma
cells (Pengo et al., 2013). Moreover, autophagy in thymic epithe-
lial cells facilitates the presentation of endogenous self-antigens
and is thus important for central CD4+ T cell tolerance (Aichinger
et al., 2013).
Importantly, autophagy is induced by numerous immune stim-
uli, including exogenous pathogen-associated molecular (PAMPs),
such as LPS (Xu et al., 2007), as well as endogenous damage-
associated molecular (DAMPs), including HMGB1 (Tang et al.,
2010a,b). Moreover, cytokines can regulate autophagy; IFN-γ,
TNF-α, IL-1α, and IL-1β all induce autophagy in macrophages
(Gutierrez et al., 2004; Harris and Keane, 2010; Shi and Kehrl,
2010), while IL-4, IL-13, and IL-10 have all been shown to inhibit
autophagy in macrophages (Harris et al., 2007, 2009; Van Grol
et al., 2010; Ní Cheallaigh et al., 2011; Park et al., 2011).
AUTOPHAGY REGULATES IL-1α, IL-1β, AND IL-18 SECRETION
Interleukin 1 family cytokines include IL-1α, IL-1β, IL-18, IL-
33, IL-36, IL-37, and IL-38 and orchestrate a wide range of
immune and physiological roles. In particular, IL-1α, IL-1β, which
signal through the same receptor (IL-1R1), have strong pro-
inflammatory effects, largely through the induction of cyclooxy-
genase type 2 (COX-2), type 2 phospholipase A, and inducible
nitric oxide synthase (iNOS) (Dinarello, 2002) and are responsi-
ble for the recruitment of myeloid cells, including neutrophils, to
sites of inflammation (Rider et al., 2011). IL-18 is similarly pro-
inflammatory and both IL-1β and IL-18 are tightly regulated; they
are produced as inactive pro-forms that are cleaved by caspase-1 to
form the mature, bioactive, cytokines. Caspase-1 is itself activated
by an inflammasome, a large multimeric structure that includes an
intracellular sensor, such as the NOD-like receptor (NLR) NLRP3
or the DNA sensor, absent in melanoma 2 (AIM2) (Davis et al.,
2011). IL-1α, while active in its pro-form, has recently been shown
to be more potent as a granzyme B-cleaved truncated peptide
(Afonina et al., 2011). Recently, studies have suggested that IL-1β
can drive the release of both IL-1α and IL-23 (Harris et al., 2008;
Fettelschoss et al., 2011), further highlighting the importance of
this cytokine in regulating inflammatory responses.
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Studies have demonstrated that autophagy can regulate the
transcription, processing, and secretion of IL-1β, as well as the
secretion of IL-1α and IL-18 (Figure 1; Table 1). This occurs
through at least two distinct mechanisms. Firstly, in macrophages
and dendritic cells, inhibition of autophagy, either pharmacolog-
ically with 3-methyladenine (3-MA) or through siRNA deletion
of autophagy genes, leads to increased release of IL-1β, IL-1α,
and IL-18 in response to TLR3 or TLR4 agonists (Saitoh et al.,
2008; Harris et al., 2011; Nakahira et al., 2011; Zhou et al., 2011a).
Typically, the release of IL-1β is a two stage process. First, tran-
scription of pro-IL-1 is induced by inflammatory stimuli (such
as LPS). This is followed by activation of inflammasome assem-
bly by a second stimulus, such as reactive oxygen species (ROS),
ATP, particulates (e.g., silica, alum), protein aggregates, or lysoso-
mal disruption. Thus, the inhibition of autophagy results in the
accumulation of a second, endogenous, inflammasome-activating
stimulus. The second mechanism is more direct; autophagosomes
can sequester and degrade inflammasome components, includ-
ing the adaptor molecule apoptosis-associated speck-like protein
containing a CARD (ASC), AIM2, and NLRP3 (Shi et al., 2012),
as well as pro-IL-1β(Harris et al., 2011). Studies have not yet
addressed whether autophagy might regulate other IL-1 family
cytokines, including IL-33, IL-36, and IL-37, but this would be
of considerable interest given role in mediating the production
and release of IL-1 and IL-18, as well as other cytokines (Saitoh
et al., 2008; Crisan et al., 2011; Harris et al., 2011; Nakahira et al.,
2011).
A ROLE FOR MITOCHONDRIA
Two studies have addressed the role of mitochondria in dri-
ving the release of IL-1β by autophagy-compromised cells. Zhou
et al. (2011a) demonstrated that inhibiting the sequestration
of mitochondria by autophagosomes (mitophagy) with 3-MA
leads to the accumulation of damaged, ROS-producing mitochon-
dria, which in turn activates the NLRP3 inflammasome, lead-
ing to the processing and release of IL-1β. Similarly, Nakahira
et al. (2011) established that depletion of the autophagy pro-
teins beclin 1 or LC3B in macrophages leads to the activation of
caspase-1 and the release of IL-1β and IL-18 by promoting the
accumulation of dysfunctional mitochondria. Moreover, secre-
tion of both cytokines was dependent on mitochondrial DNA
(mtDNA), which translocated to the cytosol, a process dependent
on ROS and NLRP3. These data would suggest that mitochondrial
dysfunction represents an endogenous stimulus for inflamma-
some activation. Studies have demonstrated that enhanced IL-
1β release by autophagy-deficient mouse cells is dependent on
FIGURE 1 | Pathways for the regulation of IL-1β by autophagy.
Autophagy regulates IL-1β production, processing, and secretion through
a number of mechanisms. In the absence of autophagy, stimulation of
macrophages or dendritic cells with TLR3 or TLR4 ligands leads to a
TRIF-dependent, mitochondrial ROS/DNA-dependent increase in the
production, processing, and secretion of IL-1β, suggesting that
autophagy normally limits the presence of these stimuli in the cytosol.
These stimuli induce inflammasome assembly, but may also increase
transcription of pro-IL-1β. Conversely, induction of autophagy in cells
stimulated with TLR ligands leads to the sequestration and lysosomal
degradation of pro-IL-1β, thus limiting the availability of the cytokine for
subsequent processing and secretion. In addition, the inflammasome
components ASC, NLRP3, and AIM2 can also be sequestered into
autophagosomes. The effects of autophagy on transcription of pro-IL-1β
are complex: autophagy down-regulates p62, which may be required for
NF-κB activation, but also down-regulates IκB, promoting NF-κB nuclear
translocation. Induction of autophagy in the presence of
inflammasome-activating stimuli, such as ATP, nigericin and particulates,
and crystals, can lead to increased secretion of IL-1β suggesting that
autophagosomes may act as part of an exocytic pathway and possibly
also a platform for inflammasome assembly, although it is not yet clear
whether fully assembled inflammasomes are sequestered.
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Table 1 | Interactions between autophagy and IL-1 family cytokines.
Interaction Notes Reference
IL-1α and IL-1β induce
autophagy
Induction of autophagy by IL-1 family cytokines suggests a potential negative feedback
loop for the control of inflammation by autophagy, as well as a possible anti-microbial
response mediated by inflammatory cytokines
Shi and Kehrl (2010)
Inhibition of autophagy
increases IL-1α, IL-1β, and
IL-18 secretion
Inhibition of (or deficiency in) autophagy leads to increased secretion of IL-1 family
cytokines in response to TLR ligands and Mycobacterium tuberculosis. This is dependent
on TRIF (in mice), reactive oxygen species, and mitochondrial DNA. These results suggest
that autophagy normally regulates endogenous factors that would otherwise induce
inflammasome assembly, caspase-1 activation, and subsequent processing and secretion
of IL-1β and IL-18. In humans, regulation of IL-1β by autophagy occurs at the transcriptional
level
Saitoh et al. (2008),
Crisan et al. (2011),
Harris et al. (2011),
Kleinnijenhuis et al.
(2011), Nakahira et al.




in vitro and in vivo
Induction of autophagy with drugs (e.g., rapamycin) or starvation reduces secretion of IL-1β
by macrophages and dendritic cells in response to LPS with alum or ATP or in response to
Mycobacterium tuberculosis. Induction of autophagy also decreases intracellular levels of
pro-IL-1β. In a mouse model of LPS-induced sepsis, rapamycin decreases serum levels of
IL-1β.
Crisan et al. (2011),
Harris et al. (2011), Shi
et al. (2012)
Autophagosomes sequester
and degrade IL-1β and
inflammasome components
In macrophages stimulated with TLR ligands, autophagosomes sequester IL-1β. The
inflammasome component ASC is ubiquitinated in response to inflammasome activation
and delivered to autophagosomes. NLRP3 and AIM2 are also sequestered by
autophagosomes
Harris et al. (2011), Shi
et al. (2012)




Induction of the AIM2 inflammasome by transfection of macrophages with poly(dA:dT) or
the NLRP3 inflammasome with uric acid crystals or nigericin leads to an increase in
autophagosome formation
Shi et al. (2012)
Autophagy can act as
secretory pathway for the
release of IL-1β
Induction of inflammasome activation in parallel with autophagy induction can lead to an
increase in IL-1β secretion. This novel secretory pathway is dependent on inflammasome
assembly, Atg5, Rab8a, and GRASP55 (GORASP2; a mammalian Golgi reassembly
stacking protein paralog)
Dupont et al. (2011)
TIR-domain-containing adapter-inducing interferon-β (TRIF),
an adaptor molecule involved in TLR3 and TLR4 signaling
(Saitoh et al., 2008; Harris et al., 2011). However, the role of
TRIF in this response is not yet known. In addition, autophagy-
deficient NLRP3−/− dendritic cells are still able to secrete IL-1β
in response to LPS (albeit at much lower levels than wild type
control cells) (Harris et al., 2011), suggesting that other inflam-
masomes may be activated by mitochondrial instability, at least
in mice.
Inhibition of autophagy with 3-MA has also been shown to
limit IL-1β transcription in humans through a process indepen-
dent of caspase-1 activation (Crisan et al., 2011; Kleinnijenhuis
et al., 2011). While the mechanism underlying these observations
is not yet clear, Lee et al. (2012) have demonstrated that autophagy
down-regulates p62, which is important for IL-1β signaling and
activation of NF-κB, which leads to increased IL-1β production.
However, this is potentially complicated by a number of stud-
ies that have demonstrated that autophagy is required for NF-κB
activation, as autophagosomes target ubiquitinated IκB for degra-
dation, allowing increased nuclear transcription of NF-κB (Meng
and Cai, 2011; Criollo et al., 2012; Jia et al., 2012). Interestingly,
in mice, inhibition of autophagy, either with 3-MA or by siRNA
targeting of beclin 1, had no effect of IL-1β transcription (Peral
de Castro et al., 2012), suggesting important differences between
mice and humans in the mechanism through which autophagy
regulates IL-1β.
AUTOPHAGY AND THE INFLAMMASOME
While inhibition of autophagy leads to increased release of IL-1β
and IL-18 (as well as IL-1α) in response to TLR3 or TLR4 lig-
ands, induction of autophagy with the mTOR inhibitor rapamycin
can inhibit IL-1β release in response to LPS with alum or ATP
(Harris et al., 2011). Moreover, activation of IL-1β transcription
with TLR agonists, in the absence of an inflammasome-inducing
signal, leads to sequestration and degradation of pro-IL-1β by
autophagosomes. This process is independent of TRIF (Harris
et al., 2011) and would suggest that autophagy acts a self-regulatory
mechanism for the control of inappropriate and potentially dele-
terious inflammatory responses. More recently, Shi et al. (2012)
have demonstrated that activation of the NLRP3 and AIM2
inflammasomes induces autophagy in macrophages. Inhibition of
autophagy with 3-MA increased inflammasome activation, while
induction of autophagy with rapamycin or amino acid starva-
tion limited it. Moreover, inflammasome components, including
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AIM2, NLRP3, and ASC partially co-localized with GFP-LC3 (an
autophagosomal marker) and LAMP-1 (a lysosomal marker) (Shi
et al., 2012), suggesting that inflammasomes are degraded within
autophagosomes. Interestingly, caspase-1 does not co-localize with
GFP-LC3 (Harris et al., 2011), suggesting that sequestration of
inflammasome components by autophagosomes is a highly spe-
cific process. Again, these data suggest that autophagy represents a
regulatory mechanism for the control of inflammatory responses
in macrophages.
A recent report has demonstrated that caspase-11 can con-
tribute to NLRP3-dependent IL-1β secretion in a TRIF-dependent
manner in response to Gram-negative bacteria. In this response,
TRIF activates caspase-11 via type I IFN signaling, which in turn
interacts with the NLRP3 inflammasome to regulate caspase-1
activation (Rathinam et al., 2012). It is not yet clear whether
autophagy intersects with this TRIF-dependent pathway to reg-
ulate caspase-11-dependent IL-1β secretion.
However, the role of autophagy in the regulation of inflam-
masome activation may not be quite so straightforward. A recent
study has demonstrated that induction of autophagy with mTOR
inhibitors or by amino acid starvation can lead to increased IL-
1β secretion in response to inflammasome-activating treatments,
including LPS with nigericin, alum, or silica crystals (Dupont et al.,
2011). This effect was partially dependent on Atg5 and at least one
of the two mammalian Golgi reassembly stacking protein par-
alogs, GRASP55 and Rab8a. In these experiments, autophagy was
induced at the same time that the inflammasome-activating stim-
ulus was added. Thus, the role of autophagy in regulating IL-1β
secretion may depend on timing and context; in the absence of
an inflammasome-activating signal, autophagy may act to remove
pro-IL-1β and inflammasome components from the cell, while in
the presence of such a signal, autophagy may act as a secretory
pathway for IL-1β release.
IL-1α AND IL-1β INDUCE AUTOPHAGY
Numerous cytokines are known to regulate autophagy in
macrophages, including IFN-γ (Gutierrez et al., 2004), TNF-α
(Harris and Keane, 2010), IL-10 (Van Grol et al., 2010; Park et al.,
2011), IL-4, and IL-13 (Harris et al., 2007). Amongst those that
have been shown to activate autophagosome formation are IL-1α
and IL-1β (Shi and Kehrl, 2010; Peral de Castro et al., 2012). More-
over, other cytokines associated with inflammatory responses,
including IL-23, have been shown to drive autophagy (Peral de
Castro et al., 2012). Thus autophagy may represent an important
mechanism in a negative feedback loop to control the secretion of
inflammatory cytokines.
FURTHER CONSEQUENCES OF AUTOPHAGIC REGULATION OF
IL-1: EFFECTS ON IL-23 AND IL-17
The regulation of IL-1β release by macrophages and DC subse-
quently affects IL-23 secretion by the same cells; inhibition of
autophagy with 3-MA or by depletion of beclin 1, leads to an
increase in IL-23 secretion, driven directly by IL-1β, while induc-
tion of autophagy with mTOR inhibitors reduces IL-23 secretion
(Peral de Castro et al., 2012). Together, IL-1 (α or β, or IL-18)
and IL-23 potently induce the secretion of IL-17 by Th17 cells
and innate γδ T cells (Sutton et al., 2009; Mills et al., 2013). Thus,
supernatants from LPS-stimulated autophagy-deficient dendritic
cells and macrophages, high in IL-1α, IL-1β, IL-18, and IL-23, have
been shown to stimulate the secretion of IL-17 by T cells, predom-
inantly γδ T cells (Peral de Castro et al., 2012). This is also relevant
in vivo, as mice lacking the autophagy protein Atg5 in myeloid
cells secrete higher levels of IL-1α, IL-12p70, CXCL1, and IL-17
in response to infection with Mycobacterium tuberculosis (Castillo
et al., 2012).
AUTOPHAGY AND INFLAMMATION IN VIVO
In humans, single nucleotide polymorphisms (SNPs) in the
autophagy-related protein 16-like 1 (atg16l1) gene have been
linked with increased susceptibility to Crohn’s disease (Hampe
et al., 2007; Rioux et al., 2007), while Mice lacking Atg16L1
in hematopoietic cells are more susceptible to dextran sulfate
sodium (DSS)-induced colitis (Saitoh et al., 2008). Similarly, poly-
morphisms in the genes encoding other autophagy-related pro-
teins, including Atg2a, Atg4a, Atg4d, Immunity-related GTPase
M (IRGM), and ULK-1, have also been associated with Crohn’s
disease (Craddock et al., 2010; Henckaerts et al., 2011; Brinar
et al., 2012). IRGM is a known modulator of autophagy in human
macrophages (Singh et al., 2006), while the mouse ortholog,
Irgm1 (formerly LRG-47), modulates IFN-γ-induced autophagy
(Gutierrez et al., 2004). Moreover, polymorphisms in IRGM have
been linked to the multifactorial autoimmune disease systemic
lupus erythematosus (SLE) (Zhou et al., 2011b), as have poly-
morphisms in Atg5 and Atg7 (Harley et al., 2008; Gateva et al.,
2009; Han et al., 2009; Zhou et al., 2011b). In mice with a
conditional deletion of Atg7 in the intestinal epithelium, LPS
induces higher levels of IL-1β mRNA, compared to wild type
controls (Fujishima et al., 2011), while LC3B−/− mice produce
higher levels of IL-1β and IL-18 in response to LPS- or cecal lig-
ation and puncture (CLP)-induced sepsis (Nakahira et al., 2011).
Moreover, autophagy has a role to play in obesity-related inflam-
mation in mice and humans. Expression of LC3 is higher in
the subcutaneous adipose tissues of obese mice and humans,
compared to lean controls and correlated with systemic insulin
resistance and adipose tissue inflammation (Jansen et al., 2012).
In addition, inhibition of autophagy with 3-MA increased the
expression of IL-1β, IL-6, and IL-8 mRNA in human adipose
tissue explants and IL-1β, IL-6, and keratinocyte-derived chemoat-
tractant (KC) mRNA in mouse explants and this effect was
greater in samples from obese individuals/animals (Jansen et al.,
2012).
CONCLUSION
Autophagy is a highly conserved and ubiquitous process that
has many roles to play in cellular homeostasis. Amongst these
is the regulation of inflammatory responses to both pathogenic
and endogenous stimuli. In particular, autophagy modulates the
transcription, processing, and secretion of IL-1β, acting as an
important negative feedback mechanism for the control of inflam-
matory responses, both in vitro and in vivo. As such, autophagy
may represent a potent target for novel anti-inflammatory
therapeutics.
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